21 April 2026
ICG plc (the “Company”)
Total Voting Rights and Transaction in Own Shares
The Company announces that in the period from 13 April 2026 to 17 April 2026, in accordance with the terms of its share buyback programme announced on 19 February 2026 (the “Share Buyback”), the Company has purchased 432,235 ordinary shares of nominal value of £0.2625 each in the capital of the Company (the "OrdinaryShares") on the London Stock Exchange through Merrill Lynch International (“BofA Securities”).
The Share Buyback is to enable the Company to issue Ordinary Non-Voting shares to Amundi equal to the number of Ordinary Shares repurchased by the Company in a manner that is non-dilutive to the Company’s existing shareholders in connection with its strategic partnership with Amundi as announced on 18 November 2025 (the “Strategic Partnership Announcement”).
Aggregated Information
| Date of Purchase: | Aggregate Number of Ordinary Shares Purchased: | Lowest Price Paid per Ordinary Share (GBP): | Highest Price Paid per Ordinary Share (GBP): | Volume-Weighted Average Price Paid per Ordinary Share (GBP): |
| 13 April 2026 | 145,993 | 1677.00 pence | 1708.00 pence | 1695.45 pence |
| 14 April 2026 | 140,341 | 1696.00 pence | 1732.00 pence | 1715.28 pence |
| 15 April 2026 | 75,390 | 1733.00 pence | 1758.00 pence | 1749.13 pence |
| 16 April 2026 | 61,631 | 1779.00 pence | 1788.00 pence | 1784.17 pence |
| 17 April 2026 | 8,880 | 1798.00 pence | 1820.00 pence | 1808.45 pence |
The Ordinary Shares acquired will be held in Treasury and will, in due course, be cancelled in tranches on at least a bi-annual basis, and will not be used for any other purpose prior to cancellation.
Total Voting Rights
Following the settlement of the Ordinary Shares purchased, the Company will have 294,373,624 Ordinary Shares in issue, of which 7,830,693 will be held in Treasury, and 3,951,459 Ordinary Non-Voting shares in issue.
The shares held in Treasury and the Ordinary Non-Voting shares do not carry voting rights. Therefore, the total number of voting rights in the Company is 286,542,931. This figure of 286,542,931 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Schedule of Purchases
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the “Market Abuse Regulation”), (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), a full breakdown of the individual trades made by BofA on behalf of the Company as part of the programme is detailed on the attached:
Terms not defined here shall have the meaning as set out in the Strategic Partnership Announcement.
Enquiries:
Chris Hunt, Head of Corporate Development and Shareholder Relations, ICG
+44 (0) 20 3545 2020
Media:
Fiona Laffan, Global Head of Corporate Affairs, ICG
+44(0)20 3545 1510
Attachment
